Product images for illustrative purposes only
Life demands more from our eyes. From digital to physical, day to night, patient's and customer’s eyes are struggling to keep up. Discover the next level family of ACUVUE® contact lenses,1 with an unprecedented combination of technologies.*1-3
The first and only†4 complete family of daily disposable contact lenses from ACUVUE® to cover patients and customers with spherical, astigmatic, presbyopic and presbyopic astigmatic vision correction needs.*2
2x reduced tear evaporation vs. DAILIES TOTAL®, MyDay® and ULTRA® ONE-Day.1,9
The highest level blue-violet light filter, with 60% blue-violet light filtering.*^1,9
100% of parameters optimised by pupil size variation across age and refraction.**10
Four stability zone design that is more resistant to gravity, minimises lower lid interaction, hassle-free application due to horizontal and vertical symmetry and delivers a prism-free optic zone.††11,12 Now optimised by cylinder power.11
Product images for illustrative purposes only
‡ n=171, || n≥449, n=172, ¶ n=172, # n=378
§ T2B descriptive summaries: n≥144
† Source: 2025 GFK sell out data, global 12 markets.
^ Versus publicly available information for standard daily use contact lenses as of December 2023.
* Filtering of HEV light by contact lenses has not been demonstrated to confer any systemic and/or ocular health benefit to the user. The Eye Care Professional should be consulted for more information.
** Compared to leading competitor’s design, technology optimised for both the parameters of refractive error and ADD power.
†† Vertical phorias possibly caused by prism dissociation due to the presence of induced optical prism is a relevant factor for practitioners to consider when fitting toric contact lenses for monocular astigmats or those requiring a mix of toric soft contact lens designs. Clinical studies have not been done to fully characterise the clinical effects of differences in base down prism among different contact lenses.
1. JJV Data on File 2022. TearStable™ Technology Definition.
2. JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM.
3. JJV Data on File: Technical Description of ACUVUE® OASYS MAX 1-DAY for ASTIGMATISM.
4. JJV Data on File 2025, World’s First and Only Daily Disposable Multifocal Toric Contact Lens.
5. JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM.
6. JJV Data on file, 2024. Subjective Comparative and Descriptive Standalone Claims for ACUVUE® OASYS MAX 1-Day Contact Lenses for ASTIGMATISM.
7. JJV Data on file 2022. CSM Subjective Responses ACUVUE® OASYS MAX 1-Day Contact Lenses – Retrospective Meta-analysis
8. JJV Data on file, 2022: Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses – Exploratory Meta-analysis.
9. JJV Data on File 2022. Material Properties: 1-DAY ACUVUE® MOIST, 1-DAY ACUVUE® TruEye®, ACUVUE® OASYS 1-Day with HydraLuxe® Technology and ACUVUE® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands.
10. JJV Data on file 2022. CSM- ACUVUE® PUPIL OPTIMISED DESIGN Technology: JJVC contact lenses, design features, and associated benefits.
11. Data on file 2024, ACUVUE® Brand Contact Lenses for ASTIGMATISM overall fitting success, orientation position, rotational stability and vision performance.
12. JJV Data on File: ACUVUE® Brand Contact Lenses for Astigmatism Technical Claims Relating to Vertical Prism Measured in the Optic Zone.
JJV Data on file, 2024: Subjective Stand-Alone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses – Exploratory Meta-analysis
13. JJV Data on file 2025. Subjective Comparative and Standalone claims for ACUVUE® OASYS MAX 1-Day Contact Lenses.
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-ifu.com. For any additional information, please visit our Johnson & Johnson website.
Third-party trademarks used herein are trademarks of their respective owners.
